Skip to main content
. 2018 Dec;10(12):6903–6911. doi: 10.21037/jtd.2018.11.127

Table 2. Survival of our patients.

Variables Survival P
Median (months) Minimum Maximum
Overall median (n=101) (Figure 1) 8 0.5 78
Gender ns
   Overall females (n=35) 7 1 78
   Overall males (n=66) 8 0.5 34
Diagnosis ns
   Overall ADC (n=71) 8 0.5 78
   Overall squamous cell carcinoma (n=13) 5 0.5 16
   Overall small-cell carcinoma (n=12) 4.5 1 17
PE
   Overall at follow-up (n=25) 11 3 78 0.009 (Figure 2)
   Overall at diagnosis (n=76) 6 0.5 35
   Overall from PE appearance (n=101) 5 0.5 35
   Overall from PE appearance at diagnosis (n=76) 6 0.5 35 <0.0001 (Figure 3)
   Overall from PE appearance during follow-up (n=25) 1 0.5 13

ADC, adenocarcinoma; PE, pleural effusion; ns, no significance.